0.6419
4.04%
+0.025
アフターアワーズ:
.642
0.000100
+0.02%
Bioline Rx Ltd ADR (BLRX) 最新ニュース
BioLineRx Reveals Cost-Saving Stem Cell Mobilization Data - TipRanks.com - TipRanks
TipRanks
BioLineRx Enhances Multiple Myeloma Treatment - TipRanks.com - TipRanks
TipRanks
What is BLRX's price-to-sales ratio telling us about the company's value? – US Post News - US Post News
US Post News
BioLineRx secures $6 million through direct offering - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
BioLineRx Announces Major Commercial Milestones - TipRanks.com - TipRanks
TipRanks
BioLineRx begins phase 2 trial for pancreatic cancer treatment - Investing.com South Africa
Investing.com South Africa
HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know - Markets Insider
Markets Insider
7 High-Potential Penny Stocks in the Biotech Sector - InvestorPlace
InvestorPlace
The 3 Best Biotech Stocks Under $1 to Buy for April - InvestorPlace
InvestorPlace
BiolineRx Has Huge Upside In 2018 (NASDAQ:BLRX) - Seeking Alpha
Seeking Alpha
Stock Update (NASDAQ:BLRX): Bioline RX Ltd Sets in Motion Phase 3 Trial for Stem Cell Mobilization Therapy BL-8040 - Yahoo Finance
Yahoo Finance
大文字化:
|
ボリューム (24 時間):